awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38247457-2CA4146A-CFE7-4ABD-A9C7-41793B393D2F
Q38247457-2CA4146A-CFE7-4ABD-A9C7-41793B393D2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38247457-2CA4146A-CFE7-4ABD-A9C7-41793B393D2F
Natural product and natural product derived drugs in clinical trials.
P2860
Q38247457-2CA4146A-CFE7-4ABD-A9C7-41793B393D2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38247457-2CA4146A-CFE7-4ABD-A9C7-41793B393D2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
790b8ca0f8616390f6545e27fb130e8b8dd004ee
P2860
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.